Related references
Note: Only part of the references are listed.Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders
S. Goriely et al.
ALLERGY (2009)
Advances in the pathogenesis and treatment of IBD
Nicholas A. Braus et al.
CLINICAL IMMUNOLOGY (2009)
Segmental colitis associated with diverticula: A rare clinical entity and a new challenge for the gastroenterologist
E. Ierardi et al.
DIGESTIVE AND LIVER DISEASE (2009)
Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver
L. Elli et al.
DIGESTIVE AND LIVER DISEASE (2009)
Modulation of TGF-beta signaling during progression of chronic liver diseases
Koichi Matsuzaki
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Primary eosinophilic disorders of the gastrointestinal tract
B. M. Yan et al.
GUT (2009)
Involvement of central immunity in uncomplicated diverticular disease
Rossella Cianci et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Diet, ageing and genetic factors in the pathogenesis of diverticular disease
Daniel Martin Commane et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Diverticular disease and diverticulitis
Anish A. Sheth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction
Michele M. Ciulla et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells
Catherine Wilson et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line
Leda Roncoroni et al.
LIVER INTERNATIONAL (2008)
Fecal calprotectin levels in patients with colonic polyposis
Raffaele Pezzilli et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Novel therapeutic approaches in IBS
Sylvie Bradesi et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine:: A 12-month follow-up
Giuseppe Comparato et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease
Tarek A. Salem et al.
DISEASES OF THE COLON & RECTUM (2007)
Long-standing colonic inflammation is associated with a low prevalence of diverticula in inflammatory bowel disease patients
Adi Lahat et al.
INFLAMMATORY BOWEL DISEASES (2007)
Immune activation in patients with irritable bowel syndrome
Tobias Liebregts et al.
GASTROENTEROLOGY (2007)
Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon
Antonio Tursi et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
How inflammation changes neuromuscular function and its relevance to symptoms in diverticular disease
Robin Spiller
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Use of Mesalazine in diverticular disease
Francesco Di Mario et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Management of diverticular disease is changing
Martin H. Floch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Review article: uncomplicated diverticular disease of the colon
L Petruzziello et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon -: A prospective, randomized, open-label study
A Tursi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Immunity, inflammation, and allergy in the gut
TT MacDonald et al.
SCIENCE (2005)
Share Paper
